PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Phenotype | |rheumatoid arthritis |
| Sentences | 72 |
| PubMedID- 23193471 | Cardiovascular disease in rheumatoid arthritis: a systematic literature review in latin america. |
| PubMedID- 22161801 | Results of prior studies have suggested that methotrexate (mtx) may improve vascular disease in patients with psoriasis and rheumatoid arthritis. |
| PubMedID- 21345288 | Lack of association between retn rs1862513 polymorphism and cardiovascular disease in rheumatoid arthritis patients. |
| PubMedID- 24498997 | Single-nucleotide polymorphisms at the 9p21.3 genomic region not associated with the risk of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 22808986 | Different techniques have proven to be useful in determining the presence of subclinical cardiovascular disease in patients with rheumatoid arthritis (ra). |
| PubMedID- 21388351 | Vascular endothelial growth factor a and cardiovascular disease in rheumatoid arthritis patients. |
| PubMedID- 20638217 | Objective: this paper describes the rationale and design of a theory-informed patient education programme addressing cardiovascular disease for people with rheumatoid arthritis (ra) to illustrate how theory can explicitly be translated into practice. |
| PubMedID- 26082375 | [pathophysiologic mechanisms and risk management of cardiovascular disease in patients with rheumatoid arthritis]. |
| PubMedID- 23079082 | Introduction: recent studies revealed that co-morbidity and mortality due to cardiovascular disease are increased in patients with rheumatoid arthritis (ra) but little is known about factors involved in these manifestations. |
| PubMedID- 22513132 | The excess risk of cardiovascular disease (cvd) associated with rheumatoid arthritis (ra) has long been recognized [1-4]. |
| PubMedID- 22657383 | Association of the methionine sulfoxide reductase a rs10903323 gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 20383550 | Atherosclerosis plays a key role in cardiovascular disease in patients with rheumatoid arthritis (ra). |
| PubMedID- 23584985 | Novel risk factors for cardiovascular disease in rheumatoid arthritis. |
| PubMedID- 21846359 | Ccr5delta32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study. |
| PubMedID- 24268008 | Cardiovascular disease in rheumatoid arthritis. |
| PubMedID- 20697481 | The collagen vascular diseases including rheumatoid arthritis (n=5) and sero negetive spondyloarthropathy (n=4) showed the maximum deterioration in range of movement from 4 to 3.1 and 3 to 2.43 respectively despite good control of the disease with disease modifying drugs and analgesics, but the range of movement score in the monoarticular group (n=22) comprising of avascular necrosis, fracture neck femur, osteoarthritis and tuberculosis showed a marginal deterioration. |
| PubMedID- 21109513 | Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives. |
| PubMedID- 21905005 | Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events. |
| PubMedID- 23818136 | Objective: to determine whether the impact of aging on cardiovascular disease (cvd) risk in patients with rheumatoid arthritis (ra) differs from that in the general population (as estimated by the framingham risk score [frs]). |
| PubMedID- 22249350 | Risk factors for cardiovascular disease in rheumatoid arthritis. |
| PubMedID- 20164773 | Cardiovascular disease in rheumatoid arthritis: a step forward. |
| PubMedID- 22927710 | Genetic markers of cardiovascular disease in rheumatoid arthritis. |
Page: 1 2